Celldex Therapeutics, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $40.3M | $42.5M | $72.1M | $28.0M | $169.4M | $24.9M | $11.9M | $21.3M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $144.8M | $195.6M | $294.9M | $205.0M | $305.2M | $85.1M | $54.7M | $62.9M |
| Property, Plant & Equipment | $10.4M | $13.2M | $11.5M | $10.5M | $10.0M | $7.2M | $9.1M | $10.8M |
| Goodwill | $91.0M | $91.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M | $9.0M |
| Intangible Assets (Excl. Goodwill) | $67.6M | $81.5M | $20.8M | $21.8M | $22.8M | $23.8M | $24.9M | $26.8M |
| Total Assets | $315.6M | $383.4M | $337.6M | $248.0M | $347.1M | $125.5M | $98.0M | $109.9M |
| Liabilities | ||||||||
| Accounts Payable | $1.7M | $1.7M | $1.5M | $2.6M | $2.2M | $745.0K | $935.0K | $931.0K |
| Total Current Liabilities | $27.7M | $35.2M | $30.2M | $24.5M | $20.4M | $17.7M | $14.3M | $20.2M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $79.3M | $117.9M | $47.5M | $36.4M | $27.3M | $29.8M | $29.3M | $34.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-812.5M | $-719.5M | $-591.0M | $-463.8M | $-345.7M | $-264.1M | $-205.0M | $-160.2M |
| Total Stockholders' Equity | $236.4M | $265.4M | $290.1M | $211.7M | $319.8M | $95.8M | $68.7M | $75.3M |